A dual-purpose container and diversion device for animals includes a base and a perimeter wall attached to the base. An inner surface and outer surface of the container combine to form an overall surface. The device includes at least a linear fault region in the overall surface having a lesser tensile strength and including at least a first non-intersecting open curve forming a first planar section; the at least a linear fault region may include at least a second curve defining a bracing component. The device is convertible to a second configuration forming a diversion device for an animal, by fracture of the at least a linear fault region to form at least a first flap and rotation of the at least a flap into a second position; conversion may include movement of the at least a bracing component to support the at least a flap in the second position.

A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a subject to treat a speech, gait or limb impairment secondary to a genetically acquired pre-frontal cortex processing disease or disorder, particularly including multiple sclerosis, cerebral palsy, Angelman syndrome, Rett syndrome and Fragile-X syndrome.

A dual-purpose container and diversion device for animals includes a base and a perimeter wall attached to the base. An inner surface and outer surface of the container combine to form an overall surface. The device includes at least a linear fault region in the overall surface having a lesser tensile strength and including at least a first non-intersecting open curve forming a first planar section; the at least a linear fault region may include at least a second curve defining a bracing component. The device is convertible to a second configuration forming a diversion device for an animal, by fracture of the at least a linear fault region to form at least a first flap and rotation of the at least a flap into a second position; conversion may include movement of the at least a bracing component to support the at least a flap in the second position.

In one embodiment, a portable animal litter system is disclosed. The system includes a base container having a perimeter wall protruding substantially upward from a perimeter of a bottom panel. A plurality of looped inner walls is positioned concentrically so that the looped inner walls are in a telescoping arrangement. In a fully collapsed state, the looped inner walls are configured within the base container such that an upper end of each of the looped inner walls are proximate to each other. In an expanded configuration the upper ends of each looped inner wall are distal from each other. A lid is configured to attach to the base container when the system is in a collapsed configuration.

Systems, devices, and methods including a base; one or more perimeter walls attached to the base; a grass mat, where the grass matt is contained within the tray by the one or more perimeter walls; and one or more removable splash guard walls, where the one or more removable splash guard walls are connected to the one or more perimeter walls.

A cat litter box is designed to be folded into a compact form for storage and shipment to a customer and unfolded by the customer for use. When it is time to replace the litter box, the cat litter box can be refolded back into a compact form for disposal. A lid protects the box during storage and shipment.

A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a subject to treat a speech, gait or limb impairment secondary to a genetically acquired pre-frontal cortex processing disease or disorder, particularly including multiple sclerosis, cerebral palsy, Angelman syndrome, Rett syndrome and Fragile-X syndrome.

A cat litter box is designed to be folded into a compact form for storage and shipment to a customer and unfolded by the customer for use. When it is time to replace the litter box, the cat litter box can be refolded back into a compact form for disposal. A lid 40 protects the box during storage and shipment.

A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a subject to treat a speech, gait or limb impairment secondary to a genetically acquired pre-frontal cortex processing disease or disorder, particularly including multiple sclerosis, cerebral palsy, Angelman syndrome, Rett syndrome and Fragile-X syndrome.

A pet crate having a top, a bottom, and a cage between the top and bottom. The cage can be engaged to and disengaged from each of the top and bottom. When engaged to the top and bottom, or when disengaged from either one or both of the top and bottom, the cage is endless and can safely hold a pet therein. When disengaged from the top and bottom, the cage is foldable into a closed, endless and flat configuration such that the cage can be stored between the top and bottom such that the crate as a whole in such stored configuration is generally flat. When disengaged from the top and bottom, the cage is foldable out into a fence configuration by disconnecting two ends of the cage.